Compare VISTA PHARMA with GRANULES INDIA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VISTA PHARMA vs GRANULES INDIA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    VISTA PHARMA GRANULES INDIA VISTA PHARMA/
GRANULES INDIA
 
P/E (TTM) x -15.8 16.8 - View Chart
P/BV x 1.5 3.7 40.1% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 VISTA PHARMA   GRANULES INDIA
EQUITY SHARE DATA
    VISTA PHARMA
Mar-21
GRANULES INDIA
Mar-21
VISTA PHARMA/
GRANULES INDIA
5-Yr Chart
Click to enlarge
High Rs16438 3.7%   
Low Rs5138 3.5%   
Sales per share (Unadj.) Rs0.3130.7 0.3%  
Earnings per share (Unadj.) Rs-0.522.2 -2.3%  
Cash flow per share (Unadj.) Rs-0.328.3 -1.1%  
Dividends per share (Unadj.) Rs01.50 0.0%  
Avg Dividend yield %00.5 0.0%  
Book value per share (Unadj.) Rs8.986.8 10.3%  
Shares outstanding (eoy) m36.79247.67 14.9%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x30.32.2 1,377.2%   
Avg P/E ratio x-20.413.0 -157.0%  
P/CF ratio (eoy) x-33.210.2 -326.2%  
Price / Book Value ratio x1.23.3 35.3%  
Dividend payout %06.8 0.0%   
Avg Mkt Cap Rs m38471,337 0.5%   
No. of employees `000NANA-   
Total wages/salary Rs m123,243 0.4%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m1332,375 0.0%  
Other income Rs m3269 1.2%   
Total revenues Rs m1632,644 0.0%   
Gross profit Rs m-178,552 -0.2%  
Depreciation Rs m71,515 0.5%   
Interest Rs m15263 5.9%   
Profit before tax Rs m-377,044 -0.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-181,549 -1.2%   
Profit after tax Rs m-195,495 -0.3%  
Gross profit margin %-136.626.4 -517.2%  
Effective tax rate %48.922.0 222.2%   
Net profit margin %-148.917.0 -877.4%  
BALANCE SHEET DATA
Current assets Rs m15219,970 0.8%   
Current liabilities Rs m9211,731 0.8%   
Net working cap to sales %473.225.4 1,859.4%  
Current ratio x1.61.7 96.8%  
Inventory Days Days2,40916 14,776.8%  
Debtors Days Days6,254863 724.7%  
Net fixed assets Rs m37417,157 2.2%   
Share capital Rs m74248 29.7%   
"Free" reserves Rs m25521,262 1.2%   
Net worth Rs m32821,510 1.5%   
Long term debt Rs m873,411 2.5%   
Total assets Rs m52637,127 1.4%  
Interest coverage x-1.427.8 -5.0%   
Debt to equity ratio x0.30.2 166.9%  
Sales to assets ratio x00.9 2.8%   
Return on assets %-0.615.5 -4.1%  
Return on equity %-5.725.5 -22.5%  
Return on capital %-5.129.3 -17.6%  
Exports to sales %081.9 0.0%   
Imports to sales %026.8 0.0%   
Exports (fob) Rs mNA26,528 0.0%   
Imports (cif) Rs mNA8,691 0.0%   
Fx inflow Rs m126,528 0.0%   
Fx outflow Rs m08,691 0.0%   
Net fx Rs m117,837 0.0%   
CASH FLOW
From Operations Rs m-674,325 -1.6%  
From Investments Rs m-3-2,771 0.1%  
From Financial Activity Rs m70-2,993 -2.3%  
Net Cashflow Rs m-1-1,441 0.1%  

Share Holding

Indian Promoters % 2.0 41.6 4.9%  
Foreign collaborators % 34.9 0.4 9,971.4%  
Indian inst/Mut Fund % 0.2 25.7 0.6%  
FIIs % 0.1 21.4 0.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 63.1 58.0 108.7%  
Shareholders   13,004 216,385 6.0%  
Pledged promoter(s) holding % 0.0 7.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare VISTA PHARMA With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

4 Reasons Why Sensex Plunged 634 Points Today(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended on a weak note.

Related Views on News

GRANULES INDIA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 20, 2021 | Updated on Oct 20, 2021

Here's an analysis of the annual report of GRANULES INDIA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of GRANULES INDIA. Also includes updates on the valuation of GRANULES INDIA.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

More Views on News

Most Popular

India's Best Semiconductor Stocks(Views On News)

Jan 7, 2022

Modern wars are fought with semiconductors. India's best semiconductor stocks have big tailwinds from defence and manufacturing.

10 Indian Companies with the Fastest Growth in Dividend Payouts...(Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain(Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

VISTA PHARMA SHARE PRICE


Jan 20, 2022 (Close)

TRACK VISTA PHARMA

  • Track your investment in VISTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

VISTA PHARMA - FDC COMPARISON

COMPARE VISTA PHARMA WITH

MARKET STATS